key: cord-0822187-4z2zqn4o
authors: Pérez Lago, Laura; Machado, Marina; Herranz, Marta; Sola-Campoy, Pedro J; Suárez-González, Julia; Martínez-Laperche, Carolina; Comas, Iñaki; Alcalá, Luis; Catalán, Pilar; Muñoz, Patricia; García de Viedma, Darío
title: Host genetic analysis should be mandatory for proper classification of COVID-19 reinfections
date: 2021-08-03
journal: Open Forum Infect Dis
DOI: 10.1093/ofid/ofab402
sha: dfa4d78b3a84016179f542dc09f3dfba730fe7ff
doc_id: 822187
cord_uid: 4z2zqn4o

nan

M a n u s c r i p t A number of SARS-CoV-2 reinfections [1] [2] [3] [4] [5] have been communicated since the first reported case in August 2020 [6] . Confirmation of reinfection was always based on differences between sequential SARS-CoV-2 strains in the first and second episodes, either major, different lineages or a large number of single nucleotide polymorphisms (SNPs), or moderate, lower diversity between the strains, but still relevant.

A recurrence is not classified as reinfection without the support of viral genomic data; however, there is a lack of this genomic rigour when documenting if the samples used to characterize the strains involved in the sequential episodes correspond to the same patient. This is essential to support viral genomics findings and demonstrate that different SARS-CoV2 strains have sequentially infected a single patient. To the best of our knowledge, only two SARS-CoV-2 reinfection studies have taken this point into consideration and have shown, supported on STRs analysis, identical host markers for the nasopharyngeal samples collected for the analyses [4, 7] .

With the striking increase of laboratory workload once the first COVID-19 wave hit, collecting sample remnants for future studies was a real challenge. Mistakes in sample labelling or in aliquoting were more likely to occur under the experienced stress. Thus, when documenting a reinfection in COVID-19, genomic data ensuring that the stored sample belongs to the same patient should be a requirement before a SARS-CoV-2 reinfection report is admitted as such.

Here, we present a COVID-19 recurrence case that met all clinical and microbiological requirements of a SARS-CoV-2 reinfection. A 61-year-old man with a history of chronic obstructive pulmonary disease, obesity, and ankylosing spondylitis, who Genomic viral analyses determined six SNPs for the SARS-CoV-2 strain, lineage 19A, obtained from the first episode, with respect to the Wuhan-1 reference sequence ( Figure   1a ). The strain from the second episode did not show any of the SNPs for the first episode strain, and carried another 16 different SNPs (Figure 1a , Table) and belonged to a different lineage, namely 20A.EU1, the primary lineage in Spain and many European countries since the end of June [8] . Based on major genomic differences between the two strains we labelled the recurrence as a reinfection.

We then performed a short tandem repeat (STR) analysis from the same total nucleic acid preparation that had been used to perform the viral genomic analysis (Supplementary_material). It revealed a different origin of the specimens due to completely different patterns for the first and second episode specimens (Figure 1b) . In fact, the material from the first episode belonged to a woman and the second one to a man, indicating mislabelling or mishandling of the specimen assigned to our (male) patient´s first episode.

The certainty of our patient´s second episode was proved by i) four sequential positive RT-PCRs, ii) 0 SNPs between the sequences from two of the SARS_CoV-2 positive specimens from his second episode and iii) STR analysis indicating that these last two specimens belonged to the same person (both males). The STR analysis revealed the reinfection was A c c e p t e d M a n u s c r i p t 6 M a n u s c r i p t 7

The patient's written consent was obtained. The design of the work has been approved by the Ethics Committee from Gregorio Marañón Hospital (Reference: MICRO.HGUGM.2020-042).

BAM files from the Sequences were deposited in ENA (EMBL) (with human sequences already filtered out) with reference PRJEB43221. along the SARS-CoV-2 chromosome for the two COVID-19 episodes. b) Human identity testing analysis was done by short tandem repeat-PCR (Mentype ® Chimera ® Biotype, Germany) on the same samples used to perform the SARS-CoV-2 RT-PCR and subsequently sequenced. Representative loci of the 12 non-coding short tandem repeat loci and the genderspecific locus amelogenin analysed. They were labelled with three different dyes (6-FAM TM , BTG, or BTY), using the Mentype ® Chimera ® PCR amplification kit (Biotype, Germany).

Alcalá (Luis), Aldámiz (Teresa), Alonso (Roberto)

Arias (Alexi)

Cercenado (Emilia)

Moure (Zaira), Muñoz (Patricia)

Pérez-Granda (María Jesús)

Reigadas (Elena)

Sánchez (Mar)

Veintimilla (Mª Cristina), Vesperinas (Lara)

Asymptomatic reinfection in two healthcare workers from India with genetically distinct SARS-CoV-2

A Case of Early Reinfection with SARS-CoV-2

Reinfection of SARS-CoV-2 in an immunocompromised patient: a case report

Mark Pandori. Genomic evidence for reinfection with SARS-CoV-2: a case study

Symptomatic SARS-CoV-2 reinfection by a phylogenetically distinct strain

COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing

Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease

Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020

This work was supported by Instituto de Salud Carlos III (Ref COV20/00140:

Consejo Superior de Investigaciones Científicas (CSIC) (PTI Salud Global). LPL has a Miguel Servet Contract (CP15/00075). We are grateful to Dainora Jaloveckas (cienciatraducida.com) for editing and proofreading assistance.

The authors declare no conflict of interest. 

A c c e p t e d M a n u s c r i p t 10 A c c e p t e d M a n u s c r i p t